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A monoclonal antibody against the murine thymus 
leukemia antigen TL, was employed to demonstrate the 
presence of the antigen on the surface of dendritic cells 
in murine epidermis of Tla-positive strains, B.lOA and 
A.TH. llll_!D.unofluorescence and immunoperoxidase 
staining of EDTA-separated epidermal sheets demon-
strated dendritic cells with a distribution pattern and 
density comparable to that noted for anti-IAk staining. 
Tla-negative mouse strains such as A.TL, C3H/HeJ, and 
C57BL/6 did not show any staining of dendritic epider-
mal cells. Epidermal cell suspensions similarly contained 
2-4% cells with discrete surface staining with anti-TL 
antibody. Capping was noted in these cells. Once again 
positive results were noted only in appropriate Tla-pos-
itive strains. Control staining was carried out in all cases 
on frozen sections of thymii from mice. Thymocytes in 
the cortical zones and some dendritic cells at the corti-
comedullary junction were stained. TL antigen in mouse 
appears to be analogous to T -6 antigen previously de-
tected on human Langerhans cells. 
The recent demonstration of the cell surface antigenic marker 
T-6 on human Langerhans cells (LCs) [1,2] has considerably 
expanded the available methods for investigations of such epi-
dermal cells. Application of T-6 as a marker, to studies of 
pathologic processes involving the skin have already been pub-
lished [3-6). In particular, the antigen is of major interest in 
permitting identification of dendritic cell types outside of the 
epidermis in various Jymphohistiocytic infiltrates. In this re-
spect T-6 is somewhat more useful than HLA-DR as a marker 
since the latter antigen, although present on LCs and indeter-
minate cells [7-9], may also be present on T lymphocytes in 
certain conditions, including cutaneous T-cell lymphomas 
(CTCL) [10-12). Attempts to relate prognosis to cellular distri-
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Abbreviations: 
CTCL: cutaneous T-celllymphoma 
FITC: fluorescein isothiocyanate 
HRP: horseradish peroxidase 
I-A k: subregion of mouse immune response gene coding for Ia 
antigens 
LC: Langerhans cell 
MHC: major histocompatibility complex 
PBS: phosphate-buffered saline 
TL: thymus leukemia (antigen) 
Tla: thymus leukemia locus located on chromosome 17 to the right 
and distal to the MHC region 
T-6: human cell surface antigen found on immature thymocytes 
and LCs 
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bution patterns or to investigate the pathogenesis of CTCLs, 
by means of HLA-DR antigen staining are clouded with uncer-
tainties over which cells are being identified. T-6 antigen ap-
pears to be restricted to immature thymocytes [13], LCs, and 
indeterminate cells. In the example of CTCLs, T -6 staining 
seems to identify only the dendritic cell components of the 
dermal infiltrates. 
Monoclonal antibodies against human antigenic determi-
nants such as T-6 have not been shown useful in investigating 
LC distribution patterns in common laboratory animals or even 
in primates such as rhesus monkeys. • This is in distinction to 
monoclonal anti-HLA-DR antibodies which are capable of de-
tecting LCs in monkey skin. 
A search was conducted for a murine equivalent of T-6 
antigen and studies were carried out on the TL antigen previ-
ously described in certain mouse strains. The antigen was 
initially described on certain radiation-induced and naturally 
occurring thymic leukemia cells [14], but was subsequently 
identified on immature thymocytes [15,16]. Staining results 
with a monoclonal anti-TL antibody indicate that-LCs express 
this antigen in appropriate TL-positive stains. TL antigen ap-
pears to be analogous to human T-6 antigen and may prove 
useful for further investigation of murine LCs in a variety of 
experimental protocols, where manipulation of this population 
of cells is the focus of attention. 
MATERIALS AND METHODS 
TL antigen, a monoclonal anti-TL immunoglobulin of the lgGz class 
(New England Nuclear, Boston, Massachusetts) , was utilized for indi-
rect immunofluorescence and immunoperoxidase staining of murine 
tissues. TL antigen present on the cell surface of mouse thymocytes of 
leukemic mice and immature thymocytes of selected normal mouse 
strains was used as irnmunogens for immunization of A.TL mice, i.e., A 
leukemia ASLI thymocytes. Monoclonal antibodies were obtained by 
fusion of splenocytes with mouse myeloma cells. The antibody fixes 
complement and has the same binding specificity as conventional anti-
TL alloantisera. The antibody was used as a high-titer ascitic fluid. 
Approximate figures for the titer in a cytolytic assay were 1.5 X 10- 5 for 
50% release. The product was stored at -70°C until use. It was aliquoted 
with buffer containing 5% bovine serum albumin and diluted to appro-
priate strengths. 
Isolated Epidermal Sheets 
Depilated body wall and ear epidermis was separated after exposure 
to EDTA [17]. After washing in phosphate-buffered saline (PBS), 
sheets were fixed in acetone at -20°C and stained by a procedure 
similar to that described for Ia' antigen [18]. 
Animals I 
Adult mice of TL-positive strains A.TH and B.10A and TL-negative 
strains A.TL, C3H/HEJ, and C57BL/6 were employed for all studies. 
Conventional housing was used. The H-2 haplotypes and TLreactivities 
are shown in Table I. 
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TABLE I. H-2 halo types and Tla genotypes of mouse strains 
Mouse s train H-2 haplotype Tla genotype 
ATH k2 + 
BIO.A a + 
ATL tl - or questionable 
C3H/ HEJ k 
C57BL/6 b 
' Source: Klein J, Flaherty L, Van de Berg JL and Shreffler DC: 
Immunogenetics 6:489-512, 1978. 
Immunofluorescence 
After exposure to primary anti-TL antibody overnight and extensive 
washing in PBS, the epidermal sheets were exposed to IgG fraction 
goat antimouse IgG labeled with fluorescein isothiocyanate (FITC) 
[18). The sheets were mounted dermal side uppermost in glycerol/ 
gelatin and viewed on a Nikon fluorescence microscope. Dilutions of 
primary antibody from 1:100 to 1:3000 were used. 
I mmunoperoxidase 
The initial procedural step WB;S as above, but the secondary reagent 
was horseradish peroxidase (HRP)-labeled goat antimouse lgG. Local-
ization of the label was achieved by incubation in peroxidase staining 
mixture with amino-ethyl carbazol and H 20 2• 
Cell Suspension 
Epidermal cell suspensions were produced by a modification of the 
method of Yuspa et al [19]. Epidermis was stripped after flotation on 
Hanks' solution (Ca++ and Mg++ free) plus 0.25% trypsin, penicillin, 
and streptomycin for 20 h at 4 °C. The cells were dispersed by mincing 
into Hanks' solution plus 0.25% trypsin and 20 1-1g/ rnl DNAase all for 30 
min at 37°C. Staining was carried out with the above reagents with 
short incubation times (see Frozen Sections) after filtration through 
nylon mesh, washing, and centrifugation. Cells were stained unfixed at 
4°C or after fixation in 2% phosphate-buffered paraformaldehyde for 
15 min at room temperature. 
Frozen Sections 
Thymii were obtained from young mice and frozen sections prepared 
at 5 1-1m. Staining of sections employed the same reagents as above, but 
exposure tissues were limited to 1 h for both primary and secondary 
reagents. Both immunofluorescence and peroxidase methods were used. 
Anti-Ia" Staining 
Staining of separated epidermal sheets or cell suspensions was carried 
out as for TL staining [18). An alloantiserum (A.TH anti-A.TL) (Ce-
darlane Labs/ Accurate Chemical, Hicksville, N ew York) was employed 
as the primary reagent. 
Controls 
The standard controls for both immunofluorescence and immuno-
peroxidase methods were employed [20) i.e. , substitution of normal 
mouse serum for the primary antibody, omission of primary antibody, 
and exposure to free HRP or FITC. 
RESULTS 
The separated epidermal sheets showed positive staining of 
dendritic cells in both fluorescent and peroxidase-labeling 
methods (Fig 1) . The staining was clearly associated with 
dendritic cells and dendritic processes lying between the kera-
tinocytes. A dilution of 1:1000 of the primary antibody gave 
localization of cells that was similar to that seen for anti-Iak 
antibody (Fig 2). Only TL-positive strains A.TH and B.10A 
showed staining. The staining intensity was considerably 
weaker than that achieved for anti-Ia\ but was nevertheless 
positive. 
Isolated cell suspension from the above TL-positive strains 
showed a strong staining of the cell surface of a minor subpop-
ulation (2-4%) of epidermal cells (Fig 3). No staining of the 
keratinocyte cell surfaces was detected. In unfixed preparation 
exposed to primary antibody there was evidence of capping and 
loss of stain (Fig 4). A similar low percentage of cells was also 
positive for Iak antigens (except for A.TH which does not stain 
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FIG 1. Isolated epidermal sheet from an A.TH strain mouse. Fluo-
rescent anti-TL staining of dendritic cells (arrows). X 750. 
FIG 2. B.10A mouse epidermal sheet. Fluorescein anti-la" staining 
of dendritic cells. X 150. 
with anti-Iak antisera). No staining was detected in TL-negative 
strains. 
Frozen sections of thymii showed staining of the cell surface 
of numerous thymocytes in the cortical zone, as well as some 
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FIG 3. Epidermal cell suspension. A.TH mouse. Aldehyde fixed. 
Peroxidase anti-TL staining (arrows). x 400. 
/ 
FIG 4. Epidermal cell suspension. A.TH mouse. Unfixed peroxidase 
anti-TL staining. Relocation or capping of stain (arrows). X 1500. 
large dendritic cells at the corticomedullary junction (Fig 5). 
Thymus cell suspension showed discrete speckled staining of 
the cell swfaces of the thymocytes. Redistribution or capping 
of the stain reaction product was noted in unfixed specimens. 
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FIG 5. Frozen section of B.lOA mouse thymus. Peroxidase anti-TL 
staining. Thymocytes in the cortex (C) (arrows) show sw-face stain. 
Dendritic cells at the corticomedullary junction also stained (arrow· 
heads). Medulla (M) X 250. 
Once again, TL-negative strains did not show any staining 
reaction activity. All controls for immunofluorescence or im-
munoperoxidase techniques were negative. 
DISCUSSION 
Investigations of cell smface antigenic markers of different 
subsets and stages of differentiation of T lymphocytes have 
uncovered intriguing links between the thymus and the skin 
[21]. While this association has been well known for many 
years, the sharing ofT-6 antigen by both immature thymocytes 
and epidermal LCs has come as somewhat of a smprise (1,2, 
22,23]. The suggestion has been advanced that LCs may be of 
a separate lineage from classical monocytes (24) or that they 
represent a unique line of differentiation in which T-6 antigen 
is expressed only as a result of their association with a keratin -
izing microenvironment. In this respect, it is not necessary to 
suggest that immature thymocytes and LCs are related, since 
unrelated cells such as T cells and cells in the brain also share 
antigens in mice, such as Thy-1. T-6 positive cells have been 
identified in the cortex of the thymus and also in small numbers 
in human lymph nodes [25]. In such locations they are found in 
paracortical areas and probably represent the distinctive inter-
digitating reticulum cells [26]. The possibility that LCs and 
interdigitating reticulum cells are related and distinct from 
phagocytic macrophage/monocyte cells has also been suggested 
[27]. 
While much interest has been raised by the demonstration of 
Ia antigens on epidermal LCs [7,8,28,29], the finding that acti-
vated T lymphocytes [30), as well as B lymphocytes, express 
the surface marker has made application of such a marker 
protein less useful. Nevertheless, this finding has contributed 
markedly to studies implicating LCs in a variety of immune 
phenomena affecting the skin [31- 33]. The existence of T -6 
antigen not only on LCs but also on indeterminate cells has 
proved even more interesting in investigations of normal and 
pathologic specimens of skin. It is a further independent marker 
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of the particular dendritic cell lineage . The demonstration of 
increased numbers of T-6 positive dendritic cells in the infil-
trates of CTCLs and other lymphocytic conditions centered on 
the skin [6) confirms some other speculations about the involve-
ment of such cells in these disease processes [34-37). 
Unfortunately the monoclonal antibodies available against 
T-6 antigens are not reactive with related or similar proteins on 
LCs in commonly used experimental a nimals. Earlier investi-
gations on murine leukemia antigens, however, may have iden-
tified antigens th at are analogous with huma n T-6 [38,39). 
Cotner and colleagues [ 40] have investigated the M ,.s and tissue 
distribution of isolated T-6. T-6 has a 49,000 M,. and this is 
associated with a 12,000 dalton chain which appears to be 
similar, if not identical, to ,82-microglobulin [ 41]. Other inves-
tigators have used isoelectric focusing a nd two-dimensional gel 
electrophoresis to investigate T -6 antigen from MOLT -4 lym-
phocytic cell lines [ 42,43]. The tissue distribution, M ,., and 
association with ,82-microglobulin support the suggestion that 
T-6 is th e human h omologue of TL. TL has a 48,000 M ,. a nd 
also is associated with a 12,000 dalton chain [ 40]. Several 
featw·es of the TL a ntigen are of interest for further investiga-
tions of human T -6. In contrast to the polymorphism exhibited 
in mice by t h e H-2K and D regions, at present only 6 allelic 
forms of Tla a1·e known [39,44]. No reports of private determi-
nants have yet appeared. TL antigen coded for by the TLa 
region can appear on leukemic cells of mice with no normal 
expression of the antigen on thymocytes. The limited polymor-
phism apperu·s to be similru· for T -6 in that no variations were 
detected in 19 individuals and 4 leukemia cell lines tested 
[42,43). MOLT-4 T-6 varies only in the possession of an extra 
sialic acid residue. No T-6-negative individuals have yet been 
demonstrated. It may be that the findings in mice ru·e related 
to the inbreeding involved in producing the selected strains. 
Amino acid sequencing will be necessru·y before the proof of 
homology between T-6 and TL may be obtained. 
TL antigen is also of interest in that it provides an excellent 
example of antigenic modulation. These findings s tem from the 
studies in which attempts were made to immunize mice against 
TL antigens. No protection was found when TL-beru·ing leu-
kemia cells were given to syngeneic immunized TL-negative 
mice [45-47). That this resulted from antibody-mediated loss 
of antigens from the surface of cells and did not represent 
simple blocking, has been shown. It is dependent on tempera-
ture and may be influenced by metabolic inhibitors. Similarly, 
the redis tribution of TL antigens, although resembling capping, 
is not identical in that it may be achieved by use of Fab 1 
fragments [ 47]. Such cells become refractory to lysis on t he 
addition of complement. 
The observations described h erein indicate that Tl a ntigen is 
resistant to paraformalin fixation and with appropriate antisera 
may be detected in a similar morphologic distribution to that 
already well described for human LCs (if anti-T-6 or anti-HLA-
DR antibodies are used). A seru·ch is already under way to 
determine whether T-6-positive cells may exist in the peripheral 
blood even if in very limit.ed numbers. With respect to TL in 
mice, reports have been published suggesting TL-bearing lym-
phocytes may exist in the ciJ·culation [ 48]. Further investiga-
tions are also warranted of the small number of dendritic TL-
positive cells noted h erein at the corticomedullary junction of 
the thymus. Previous investigations have concentrated on the 
immature thymocytes, and the existence of such a small sub-
population of denru·itic cells has escaped attention. 
The growing awareness of the involvement of denru·itic cells 
in various immune phenomena and their possible separation 
from more conventional monocyte/ macrophage cell types, im-
plies that further comparison between T-6 staining results in 
humans and TL staining patterns in mice may be of great 
interests. 
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In Vivo Mobilization of Polymorphonuclear Leukocytes in Psoriasis: 
Relationship to Clinical Parameters and Serum Inhibitory Factors 
MAJA TIGALONOWA, M.D., WIESLAW GLINSKI, M.D., AND STEFANIA JABLONSKA, M .D. 
Department of Dermatology, Academy of Medicine, Warsaw, Poland 
Mean migration of polymorphonuclear leukocytes 
(PMNL) toward autologous and homologous control 
sera, evaluated by quantitative skin window chamber 
technique, was .only slightly reduced in 60 patients with 
psoriasis as compared to 27 normal controls (p < 0.1). A 
significant decrease in cell migration was found (1) in 
patients with actively spreading lesions, (2) in patients 
with extensive lesions involving more than 40-60% of 
the skin surface, (3) in the first 2 months of relapse, and 
(4) 5-6 months after onset of new lesions. However, 
PMNL migration was increased when psoriatic lesions 
lasted 3-4 months. Seventy-one percent of psoriatic sera 
exerted a suppressive effect on the psoriatic and normal 
PMNL migration. The inhibitors were found predomi-
nantly in patients with stationary and long-standing 
lesions. Some of the psoriatic sera had a stimulatory 
effect on the chemotaxis of psoriatic PMNL. These sera 
originated from those patients with active spreading 
lesions in the first 2 months of relaps_e. · 
These data indicate that neutrophil migration is ab-
normal in the course of psoriasis and that it could be 
Manuscript received April 5, 1982; accepted for publication Novem-
ber 30, 1982. 
Reprint requests to: Wieslaw Glmski, M.D., Department of Derma-
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Abbreviations: 
HBSS: Hanks' balanced salt solution 
PMNL: polymorphonuclear leukocytes 
modified by different proportions of both inhibitors and 
stimulators of chemotaxis. 
Polymorphonuclear leukocytes (PMNL) seem to play an 
important role in the pathogenesis of psoriasis. They are a 
constant constitl,lent of inftltrates of early psoriatic papules 
[1,2). Their chemotaxis in vitro toward different attractants [3-
6], their adherence [7], oxidative system function [8], and the 
intracellular content of neutral proteinases [9] were found to be 
increased. 
In in vitro chemotaxis studies using the Boyden chamber 
method, inhibitors and stimulators of PMNL migration were 
detected in psoriatic serum [10-13]. Stimulatory activity was 
directed toward psoriatic neutrophils [12] and also toward 
normal cells [13]. The inhibitors of PMNL function were pre-
sent in patients with widespread [11] and long-standing [13] 
psoriatic lesions. 
Breathnach et al [14], using a quantitative skin window 
chamber technique, have found that in vivo migration of PMNL 
toward 50% autologous serum in patients with psoriatic lesions 
involving more than 25% of the skin surface was lower than in 
patients with minor skin involvement and in normals. In con-
trast, in cases of untreated psoriasis Dubertret et al [15] re-
ported on an increased penetration of cells within 8 h through 
skin window. More detailed studies on larger series of patients 
with an account of clinical parameters have not been reported. 
The purpose of our study was to analyze by the quantitative 
skin window chamber technique: (1) migration of PMNL as 
related to the activity of the disease, the duration of the relapse, 
and the extent of psoriatic lesions, and (2) the effect of normal 
and psoriatic sera on PMNL migration through the skin win-
dow. 
